About Us

https://www.medidect.com/wp-content/uploads/2023/04/logo.png
About Us

Medidect™ India

Millennium Oncology India Private Limited (operating under trade name Medidect™ India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for tumors screening across India. We are legally registered under the name of MILLENNIUM ONCOLOGY INDIA PRIVATE LIMITED

PanTum® Detect is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE and Indian registration, Pantum® Detect is the first, and so far, the only multi tumor scanner for fast and inexpensive tumor screening by combining Imaging technology for confirmation and localization of tumors.

Medidect™ India will build and leverage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.
https://www.medidect.com/wp-content/uploads/2022/10/logo.png
About Us

Medidect™ India

Millennium Oncology India Private Limited (operating under trade name Medidect™ India) has partnered with Zyagnum AG, acquiring exclusive rights to deploy a breakthrough technology for early detection of all cancers across India.

PanTum Detect® is a simple, safe, non-invasive blood test with ground-breaking accuracy. The high specificity of 99%, combined with the high sensitivity of 97.5% is validated and unique to this day. With the successful IVD CE certification, Pantum Detect® is the first, and so far, the only universal (all cancer types) test for fast and inexpensive cancer screening.

Medidect™ India will build and levarage existing capabilities and infrastructure of select players across the Indian healthcare ecosystem, typically Providers & Payors of medical cost. Early detection will trigger a much needed shift from complex late stage treatment to prevention and timely treatment with improved clinical outcomes at much lower costs.

Our Vision

Towards a healthy & cancer free India.

Our Mission

Enable early-stage detection of tumors through affordable mass screening with PanTum® Detect.

Our Strategic Direction

  1. Our team will lead the change to transform the healthcare eco-system towards mass annual multi-cancer screening for definitive early-stage diagnosis, timely treatment and protection against late-stage cancer.
  2. Build infrastructure & testing capacity ahead of demand
  3. Achieve mass scale access through mutually beneficial partnerships with Healthcare Providers & Payors of medical costs.
  4. Enroll reputed Healthcare providers into an integrated and connected prevention, wellness and cancer care network
  5. Leverage global know-how and multicountry network for global expansion.

OUR EXPERTSFounding Members

https://www.medidect.com/wp-content/uploads/2023/01/Dr.-Sethi.jpg
CO-FOUNDER & DIRECTOR

Dr. Gurdeep Singh Sethi, MD

Founder & Director, Millennium Cancer Center, India. Has over 30 years of experience in cancer management and immuno-oncology. He has spent over 26 years in the USA as a Senior Partner at an oncology chain. Practicing in India since 2015.
https://www.medidect.com/wp-content/uploads/2022/10/GSBEDI-SIR-e1643113875215.jpg
CO-FOUNDER & DIRECTOR

Gagandeep Singh Bedi

Healthcare leader bringing over 30 years of experience from roles at Philips Healthcare & Fortis Healthcare. With expertise in healthcare spanning Europe, Middle East, Africa, South America, South-east Asia and India, he holds deep understanding of healthcare delivery and financing.
https://www.medidect.com/wp-content/uploads/2022/10/ANDREAS-e1643113930711.png
CO-FOUNDER & DIRECTOR

Andreas Klein

Over 25 years in leadership roles in Europe, US, China and Asia and experience in international business management . He is also an advisor to the board of Zyagnum.

Leadership Team

https://www.medidect.com/wp-content/uploads/2023/02/eb45eea4-b48e-409a-b382-0e7bee833e93-e1676711042548.jpg
Chief Operating Officer

Shiv Sagar Suri

Over 20 years in business development Advisory in Healthcare industry. Consulted with both Indian & International Companies for Market Expansion & Strategic Alliances. Was a Steering Committee Member of The Future Global Healthcare Hub (a PHD Chamber of Commerce & Industry Initiative).
https://www.medidect.com/wp-content/uploads/2022/10/Dr.Pramod-1.jpg
Lab Director

Dr. Pramod Nath

Renowned Oncopathologist with 32 yrs of total experience in healthcare industry including 23 yrs in Armed Forces. Expertise in Histopathology & Cytology. Has been lab director & HOD in reputed hospitals.

Professional Advisors

https://www.medidect.com/wp-content/uploads/2022/10/RajivKapahi1-1.jpg
Advisor

Rajiv Kapahi

Over 3 decades of experience in multi-industry domain as CXO & Board level engagements across MNC’s & Indian Business Houses in Healthcare, Insurance, IT / ITES, FMCG, Manufacturing & Office Automation sectors in India, APAC & EMEA.